# A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod

> **NCT05927415** · PHASE1 · COMPLETED · sponsor: **argenx** · enrollment: 33 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **BIOLOGICAL:** Efgartigimod IV

## Key facts

- **NCT ID:** NCT05927415
- **Lead sponsor:** argenx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-17
- **Primary completion:** 2024-06-12
- **Final completion:** 2024-06-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2024-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05927415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05927415, "A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05927415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*